\begin{thebibliography}{10}
\providecommand \doibase [0]{http://dx.doi.org/}%

\bibitem{world2014global}
WHO WHO, others . {\it Global Status Report on Noncommunicable Diseases 2014}.
\newblock No.~WHO/NMH/NVI/15.1World Health Organization .
\newblock 2014.

\bibitem{bokhorst2015compliance}
Bokhorst LP, Alberts AR, Rannikko A, et al. Compliance rates with the {Prostate
  Cancer Research International Active Surveillance (PRIAS)} protocol and
  disease reclassification in noncompliers. {\it European Urology} 2015\string;
  68(5)\string: 814--821.

\bibitem{weusten2017endoscopic}
Weusten B, Bisschops R, Coron E, et al. Endoscopic management of {Barrett's}
  esophagus: European Society of Gastrointestinal Endoscopy ({ESGE}) position
  statement. {\it Endoscopy} 2017\string; 49(02)\string: 191--198.

\bibitem{krist2007timing}
Krist AH, Jones RM, Woolf SH, et al. Timing of repeat colonoscopy: disparity
  between guidelines and endoscopistsâ€™ recommendation. {\it American Journal
  of Preventive Medicine} 2007\string; 33(6)\string: 471--478.

\bibitem{mcwilliams2008surveillance}
McWilliams TJ, Williams TJ, Whitford HM, Snell GI. Surveillance bronchoscopy in
  lung transplant recipients: risk versus benefit. {\it The Journal of Heart
  and Lung Transplantation} 2008\string; 27(11)\string: 1203--1209.

\bibitem{loeb2013systematic}
Loeb S, Vellekoop A, Ahmed HU, et al. Systematic review of complications of
  prostate biopsy. {\it European Urology} 2013\string; 64(6)\string: 876--892.

\bibitem{LeClercq2015325}
Le~Clercq C, Winkens B, Bakker C, et al. Metachronous colorectal cancers result
  from missed lesions and non-compliance with surveillance. {\it
  Gastrointestinal Endoscopy} 2015\string; 82(2)\string: 325-333.e2.

\bibitem{alagoz2010operations}
Alagoz O, Ayer T, Erenay FS. {\it Operations Research Models for Cancer
  Screening}.
\newblock American Cancer Society .
\newblock 2011.

\bibitem{steimle2017markov}
Steimle LN, Denton BT. {\it Markov Decision Processes for Screening and
  Treatment of Chronic Diseases}.
\newblock Springer International Publishing .
\newblock 2017.

\bibitem{vickers2006decision}
Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating
  prediction models. {\it Medical Decision Making} 2006\string; 26(6)\string:
  565--574.

\bibitem{tomer2019personalizedbiometrics}
Tomer A, Nieboer D, Roobol MJ, Steyerberg EW, Rizopoulos D. Personalized
  schedules for surveillance of low-risk prostate cancer patients. {\it
  Biometrics} 2019\string; 75(1)\string: 153--162.

\bibitem{bebu2017optimal}
Bebu I, Lachin JM. Optimal screening schedules for disease progression with
  application to diabetic retinopathy. {\it Biostatistics} 2017\string;
  19(1)\string: 1--13.

\bibitem{rizopoulos2015personalized}
Rizopoulos D, Taylor JM, Van~Rosmalen J, Steyerberg EW, Takkenberg JJ.
  Personalized screening intervals for biomarkers using joint models for
  longitudinal and survival data. {\it Biostatistics} 2015\string;
  17(1)\string: 149--164.

\bibitem{tomer2019personalized}
Tomer A, Rizopoulos D, Nieboer D, Drost FJ, Roobol MJ, Steyerberg EW.
  Personalized Decision Making for Biopsies in Prostate Cancer Active
  Surveillance Programs. {\it Medical Decision Making} 2019\string;
  39(5)\string: 499--508.

\bibitem{wang2019learning}
Wang Y, Zhao YQ, Zheng Y. Learning-based biomarker-assisted rules for optimized
  clinical benefit under a risk-constraint. {\it Biometrics} 2019.

\bibitem{tsiatis2004joint}
Tsiatis AA, Davidian M. Joint modeling of longitudinal and time-to-event data:
  an overview. {\it Statistica Sinica} 2004\string; 14(3)\string: 809--834.

\bibitem{rizopoulos2012joint}
Rizopoulos D. {\it Joint Models for Longitudinal and Time-to-Event Data: With
  Applications in R}.
\newblock CRC Press .
\newblock 2012.

\bibitem{mcculloch2005generalized}
McCulloch CE, Neuhaus JM. Generalized linear mixed models. {\it Encyclopedia of
  Biostatistics} 2005\string; 4.

\bibitem{loeb2014overdiagnosis}
Loeb S, Bjurlin MA, Nicholson J, et al. Overdiagnosis and overtreatment of
  prostate cancer. {\it European Urology} 2014\string; 65(6)\string:
  1046--1055.

\bibitem{epsteinGG2014}
Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA. The 2014
  International Society of Urological Pathology ({ISUP}) consensus conference
  on {Gleason} grading of prostatic carcinoma. {\it The American Journal of
  Surgical Pathology} 2016\string; 40(2)\string: 244--252.

\bibitem{loeb2014heterogeneity}
Loeb S, Carter HB, Schwartz M, Fagerlin A, Braithwaite RS, Lepor H.
  Heterogeneity in active surveillance protocols worldwide. {\it Reviews in
  Urology} 2014\string; 16(4)\string: 202--203.

\bibitem{GlobalCancerStats2012}
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global
  cancer statistics, 2012. {\it CA: A Cancer Journal for Clinicians}
  2015\string; 65(2)\string: 87--108.

\bibitem{brown2009assessing}
Brown ER. Assessing the association between trends in a biomarker and risk of
  event with an application in pediatric {HIV/AIDS}. {\it The Annals of Applied
  Statistics} 2009\string; 3(3)\string: 1163--1182.

\bibitem{taylor2013real}
Taylor JM, Park Y, Ankerst DP, et al. Real-time individual predictions of
  prostate cancer recurrence using joint models. {\it Biometrics} 2013\string;
  69(1)\string: 206--213.

\bibitem{eilers1996flexible}
Eilers PH, Marx BD. Flexible smoothing with {B-splines} and penalties. {\it
  Statistical Science} 1996\string; 11(2)\string: 89--121.

\bibitem{cook1994equivalence}
Cook RD, Wong WK. On the equivalence of constrained and compound optimal
  designs. {\it Journal of the American Statistical Association} 1994\string;
  89(426)\string: 687--692.

\bibitem{sassi2006calculating}
Sassi F. Calculating {QALYs}, comparing {QALY} and {DALY} calculations. {\it
  Health Policy and Planning} 2006\string; 21(5)\string: 402--408.

\bibitem{de2017should}
Carvalho dTM, Heijnsdijk EA, Koning dHJ. When should active surveillance for
  prostate cancer stop if no progression is detected?. {\it The Prostate}
  2017\string; 77(9)\string: 962--969.

\bibitem{rizopoulosJMbayes}
Rizopoulos D. The {R} Package {JMbayes} for Fitting Joint Models for
  Longitudinal and Time-to-Event Data Using {MCMC}. {\it Journal of Statistical
  Software} 2016\string; 72(7)\string: 1--46.

\bibitem{landmarking2017}
Rizopoulos D, Molenberghs G, Lesaffre EM. Dynamic predictions with
  time-dependent covariates in survival analysis using joint modeling and
  landmarking. {\it Biometrical Journal} 2017\string; 59(6)\string: 1261--1276.

\bibitem{carvalho}
Carvalho dTM, Heijnsdijk EA, Koning dHJ. Estimating the risks and benefits of
  active surveillance protocols for prostate cancer: a microsimulation study.
  {\it BJU International} 2017\string; 119(4)\string: 560--566.

\bibitem{inoue2018comparative}
Inoue LY, Lin DW, Newcomb LF, et al. Comparative Analysis of Biopsy Upgrading
  in Four Prostate Cancer Active Surveillance Cohorts. {\it Annals of Internal
  Medicine} 2018\string; 168(1)\string: 1--9.

\bibitem{balasubramanian2003estimation}
Balasubramanian R, Lagakos SW. Estimation of a failure time distribution based
  on imperfect diagnostic tests. {\it Biometrika} 2003\string; 90(1)\string:
  171--182.

\bibitem{coley2017prediction}
Coley RY, Zeger SL, Mamawala M, Pienta KJ, Carter HB. Prediction of the
  pathologic {Gleason} score to inform a personalized management program for
  prostate cancer. {\it European Urology} 2017\string; 72(1)\string: 135--141.

\end{thebibliography}
